The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

Endogenous catalase delays high-fat diet-induced liver injury in mice

  • Piao, Lingjuan (Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University) ;
  • Choi, Jiyeon (Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University) ;
  • Kwon, Guideock (Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University) ;
  • Ha, Hunjoo (Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University)
  • Received : 2016.11.26
  • Accepted : 2017.03.03
  • Published : 2017.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease in parallel with worldwide epidemic of obesity. Reactive oxygen species (ROS) contributes to the development and progression of NAFLD. Peroxisomes play an important role in fatty acid oxidation and ROS homeostasis, and catalase is an antioxidant exclusively expressed in peroxisome. The present study examined the role of endogenous catalase in early stage of NAFLD. 8-week-old male catalase knock-out (CKO) and age-matched C57BL/6J wild type (WT) mice were fed either a normal diet (ND: 18% of total calories from fat) or a high fat diet (HFD: 60% of total calories from fat) for 2 weeks. CKO mice gained body weight faster than WT mice at early period of HFD feeding. Plasma triglyceride and ALT, fasting plasma insulin, as well as liver lipid accumulation, inflammation (F4/80 staining), and oxidative stress (8-oxo-dG staining and nitrotyrosine level) were significantly increased in CKO but not in WT mice at 2 weeks of HFD feeding. While phosphorylation of Akt (Ser473) and $PGC1{\alpha}$ mRNA expression were decreased in both CKO and WT mice at HFD feeding, $GSK3{\beta}$ phosphorylation and Cox4-il mRNA expression in the liver were decreased only in CKO-HF mice. Taken together, the present data demonstrated that endogenous catalase exerted beneficial effects in protecting liver injury including lipid accumulation and inflammation through maintaining liver redox balance from the early stage of HFD-induced metabolic stress.

Keywords

References

  1. Suzuki A, Angulo P, Lymp J, St Sauver J, Muto A, Okada T, Lindor K. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology. 2005;41:64-71. https://doi.org/10.1002/hep.20543
  2. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143:722-728. https://doi.org/10.7326/0003-4819-143-10-200511150-00009
  3. Basaranoglu M, Basaranoglu G, Senturk H. From fatty liver to fibrosis: a tale of "second hit". World J Gastroenterol. 2013;19:1158-1165. https://doi.org/10.3748/wjg.v19.i8.1158
  4. Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H, Ota T, Yokoyama M, Honda M, Miyamoto K, Kaneko S. Increased oxidative stress precedes the onset of high-fat dietinduced insulin resistance and obesity. Metabolism. 2008;57:1071-1077. https://doi.org/10.1016/j.metabol.2008.03.010
  5. Diehl AM. Lessons from animal models of NASH. Hepatol Res. 2005;33:138-144. https://doi.org/10.1016/j.hepres.2005.09.022
  6. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752-1761. https://doi.org/10.1172/JCI21625
  7. Podrini C, Borghesan M, Greco A, Pazienza V, Mazzoccoli G, Vinciguerra M. Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). Curr Pharm Des. 2013;19:2737-2746. https://doi.org/10.2174/1381612811319150009
  8. Touyz RM, Briones AM. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens Res. 2011;34:5-14. https://doi.org/10.1038/hr.2010.201
  9. Knebel B, Hartwig S, Haas J, Lehr S, Goeddeke S, Susanto F, Bohne L, Jacob S, Koellmer C, Nitzgen U, Muller-Wieland D, Kotzka J. Peroxisomes compensate hepatic lipid overflow in mice with fatty liver. Biochim Biophys Acta. 2015;1851:965-976. https://doi.org/10.1016/j.bbalip.2015.03.003
  10. Park HS, Jang JE, Ko MS, Woo SH, Kim BJ, Kim HS, Park HS, Park IS, Koh EH, Lee KU. Statins increase mitochondrial and peroxisomal fatty acid oxidation in the liver and prevent nonalcoholic steatohepatitis in mice. Diabetes Metab J. 2016;40:376-385. https://doi.org/10.4093/dmj.2016.40.5.376
  11. Wei Y, Rector RS, Thyfault JP, Ibdah JA. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol. 2008;14:193-199. https://doi.org/10.3748/wjg.14.193
  12. Van Veldhoven PP, Vanhove G, Assselberghs S, Eyssen HJ, Mannaerts GP. Substrate specificities of rat liver peroxisomal acyl-CoA oxidases: palmitoyl-CoA oxidase (inducible acyl-CoA oxidase), pristanoyl-CoA oxidase (non-inducible acyl-CoA oxidase), and trihydroxycoprostanoyl-CoA oxidase. J Biol Chem. 1992;267:20065-20074.
  13. Fransen M, Nordgren M, Wang B, Apanasets O. Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochim Biophys Acta. 2012;1822:1363-1373. https://doi.org/10.1016/j.bbadis.2011.12.001
  14. Lismont C, Nordgren M, Van Veldhoven PP, Fransen M. Redox interplay between mitochondria and peroxisomes. Front Cell Dev Biol. 2015;3:35.
  15. Antonenkov VD, Grunau S, Ohlmeier S, Hiltunen JK. Peroxisomes are oxidative organelles. Antioxid Redox Signal. 2010;13:525-537. https://doi.org/10.1089/ars.2009.2996
  16. Okuno Y, Matsuda M, Kobayashi H, Morita K, Suzuki E, Fukuhara A, Komuro R, Shimabukuro M, Shimomura I. Adipose expression of catalase is regulated via a novel remote PPARgamma-responsive region. Biochem Biophys Res Commun. 2008;366:698-704. https://doi.org/10.1016/j.bbrc.2007.12.001
  17. Hwang I, Lee J, Huh JY, Park J, Lee HB, Ho YS, Ha H. Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes. 2012;61:728-738. https://doi.org/10.2337/db11-0584
  18. Flamment M, Rieusset J, Vidal H, Simard G, Malthiery Y, Fromenty B, Ducluzeau PH. Regulation of hepatic mitochondrial metabolism in response to a high fat diet: a longitudinal study in rats. J Physiol Biochem. 2012;68:335-344. https://doi.org/10.1007/s13105-012-0145-3
  19. Ho YS, Xiong Y, Ma W, Spector A, Ho DS. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem. 2004;279:32804-32812. https://doi.org/10.1074/jbc.M404800200
  20. Stienstra R, Mandard S, Patsouris D, Maass C, Kersten S, Muller M. Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation. Endocrinology. 2007;148:2753-2763. https://doi.org/10.1210/en.2007-0014
  21. Lee YS, Li P, Huh JY, Hwang IJ, Lu M, Kim JI, Ham M, Talukdar S, Chen A, Lu WJ, Bandyopadhyay GK, Schwendener R, Olefsky J, Kim JB. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes. 2011;60:2474-2483. https://doi.org/10.2337/db11-0194
  22. Lanthier N, Molendi-Coste O, Horsmans Y, van Rooijen N, Cani PD, Leclercq IA. Kupffer cell activation is a causal factor for hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2010;298:G107-116. https://doi.org/10.1152/ajpgi.00391.2009
  23. Elsner M, Gehrmann W, Lenzen S. Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells. Diabetes. 2011;60:200-208. https://doi.org/10.2337/db09-1401
  24. Rhee SG, Chang TS, Jeong W, Kang D. Methods for detection and measurement of hydrogen peroxide inside and outside of cells. Mol Cells. 2010;29:539-549. https://doi.org/10.1007/s10059-010-0082-3

Cited by

  1. Glycine Increases Insulin Sensitivity and Glutathione Biosynthesis and Protects against Oxidative Stress in a Model of Sucrose-Induced Insulin Resistance vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/2101562
  2. Interleukin-4 Boosts Insulin-Induced Energy Deposits by Enhancing Glucose Uptake and Lipogenesis in Hepatocytes vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/6923187
  3. Inactivation of SREBP-1a Phosphorylation Prevents Fatty Liver Disease in Mice: Identification of Related Signaling Pathways by Gene Expression Profiles in Liver and Proteomes of Peroxisomes vol.19, pp.4, 2018, https://doi.org/10.3390/ijms19040980
  4. G protein-coupled estrogen receptor (GPER) deficiency induces cardiac remodeling through oxidative stress vol.199, pp.None, 2018, https://doi.org/10.1016/j.trsl.2018.04.005
  5. Catalase and nonalcoholic fatty liver disease vol.470, pp.12, 2017, https://doi.org/10.1007/s00424-018-2195-z
  6. SIRT1 Modulators in Experimentally Induced Liver Injury vol.2019, pp.None, 2019, https://doi.org/10.1155/2019/8765954
  7. Integrative Omics Reveals Metabolic and Transcriptomic Alteration of Nonalcoholic Fatty Liver Disease in Catalase Knockout Mice vol.27, pp.2, 2017, https://doi.org/10.4062/biomolther.2018.175
  8. Saturated Fatty Acid-Enriched Diet-Impaired Mitochondrial Bioenergetics in Liver From Undernourished Rats During Critical Periods of Development vol.8, pp.4, 2017, https://doi.org/10.3390/cells8040335
  9. Reduced lifespan of mice lacking catalase correlates with altered lipid metabolism without oxidative damage or premature aging vol.135, pp.None, 2019, https://doi.org/10.1016/j.freeradbiomed.2019.02.016
  10. Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice vol.471, pp.6, 2017, https://doi.org/10.1007/s00424-018-02250-3
  11. Oxidative stress resulting from the removal of endogenous catalase induces obesity by promoting hyperplasia and hypertrophy of white adipocytes vol.37, pp.None, 2017, https://doi.org/10.1016/j.redox.2020.101749
  12. Effect of cassava flour on the lipidic and redox profile of Wistar rats with dyslipidemia vol.44, pp.11, 2017, https://doi.org/10.1111/jfbc.13457